Source:http://linkedlifedata.com/resource/pubmed/id/17083039
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2006-11-3
|
pubmed:abstractText |
Pertussis toxin (PTX) and its binding unit (PTX-B) have been shown to inhibit human immunodeficiency virus (HIV)-1 infection of primary cells. However, the anti-HIV mechanisms have yet to be defined. We demonstrate that PTX inhibits HIV-1 infection of human cervical tissue independently of viral tropism. PTX-B showed a similar pattern of HIV-1 inhibition. Further investigation in macrophages demonstrated that PTX/PTX-B inhibited HIV-1 expression but that other G protein inhibitors and activators had no effect on HIV-1 replication. Unlike the anti-HIV bacterial lipopolysaccharide, the anti-HIV effects of PTX/PTX-B were not due to beta -chemokine production or coreceptor down-modulation, but they were dependent on interaction with cell-surface receptors. Antibody blocking studies suggested that cell-surface CD14 is very likely to be the principal receptor involved in the anti-HIV effects of PTX/PTX-B. This was further strengthened by the results of surface plasmon resonance analyses. Further definition of the mechanisms of such inhibition may lead to the development of novel HIV-1 prevention strategies.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-HIV Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD14,
http://linkedlifedata.com/resource/pubmed/chemical/Chemokines, CC,
http://linkedlifedata.com/resource/pubmed/chemical/HIV Core Protein p24,
http://linkedlifedata.com/resource/pubmed/chemical/Pertussis Toxin,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Subunits,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, HIV
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0022-1899
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
194
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1547-56
|
pubmed:dateRevised |
2007-12-3
|
pubmed:meshHeading |
pubmed-meshheading:17083039-Anti-HIV Agents,
pubmed-meshheading:17083039-Antigens, CD14,
pubmed-meshheading:17083039-Cells, Cultured,
pubmed-meshheading:17083039-Cervix Uteri,
pubmed-meshheading:17083039-Chemokines, CC,
pubmed-meshheading:17083039-Female,
pubmed-meshheading:17083039-HIV Core Protein p24,
pubmed-meshheading:17083039-HIV-1,
pubmed-meshheading:17083039-Humans,
pubmed-meshheading:17083039-Macrophages,
pubmed-meshheading:17083039-Pertussis Toxin,
pubmed-meshheading:17083039-Protein Binding,
pubmed-meshheading:17083039-Protein Subunits,
pubmed-meshheading:17083039-RNA, Viral,
pubmed-meshheading:17083039-Receptors, HIV,
pubmed-meshheading:17083039-Virus Replication
|
pubmed:year |
2006
|
pubmed:articleTitle |
Pertussis toxin and its binding unit inhibit HIV-1 infection of human cervical tissue and macrophages involving a CD14 pathway.
|
pubmed:affiliation |
Center for Infection, Department of Cellular and Molecular Medicine, St. George's University of London, London SW17 0RE, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|